Darci Trader Lab
Menu
Trader lab Funding
Current Funding
NIH
R01AI50847- Monitoring and Manipulating the Activity of the Immunoproteasome with Small Molecules- 2020-2024
R21GM131206- Development of Activity-Based Chemical Reporters to Differentiate Proteasome Isoforms in Cells- 2019-2021
R21GM131206- Development of Activity-Based Chemical Reporters to Differentiate Proteasome Isoforms in Cells- 2019-2021
CTSI- Proteomics
Rpn-13 small molecule binders- 2019-2020
Purdue University Center for cancer research Grants
-Phase I Concept Award, Rpn-13 Inhibitors, 2019-2020
-Shared Resource Grant for Cryo-EM analysis of the proteasome and small molecules, 2019
-Phase II Concept Award, Rpn-6 Inhibitors 2018-2019
-Shared Resource Grant for Cryo-EM analysis of the proteasome and small molecules, 2019
-Phase II Concept Award, Rpn-6 Inhibitors 2018-2019
Showalter Trust Research Award
"Targeting Cancer Cells with an Immunoproteasome-Selective Prodrug Strategy"- 2019-2020
Purdue MCMP Start-Up
2016-2021
Previous funding
Showalter Trust Research Award
"Discovery of Proteasome Stimulators to Treat Diseases Associated with Protein Accumulation"
2017-2018
2017-2018
MCMP Research Enhancement Award
"Development of a high throughput FRET assay for screening natural products for 20S CP stimulators"
2017-2018
2017-2018
Purdue Cancer center grants
-American Cancer Society Institution Grant for New Investigators, 2016-2017
-Phase I Concept Award, Rpn-6 Inhibitors, 2017-2018
-Phase I Concept Award, Rpn-6 Inhibitors, 2017-2018
Proudly powered by Weebly